Plant ID: NPO1479
Plant Latin Name: Amomum longiligulare
Taxonomy Genus: Amomum
Taxonomy Family: Zingiberaceae
NCBI TaxonomyDB:
648859
Plant-of-the-World-Online:
n.a.
Vietnam; China
TSHR; | |
ALPI; P4HB; AKR1B1; POLB; | |
GAA; | |
MAPK1; | |
CA2; CA1; CA12; CA7; CA4; | |
PPARA; PPARD; | |
TLR2; | |
HTT; RAB9A; LMNA; NPC1; FABP3; FABP5; FABP2; FABP4; MAPT; | |
XDH; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Enzyme_unclassified | ALPI | Intestinal alkaline phosphatase | P09923 | CHEMBL5573 |
Enzyme_unclassified | P4HB | Protein disulfide-isomerase | P07237 | CHEMBL5422 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.305E-11 | 1.421E-07 | CA1, CA12, CA2, CA4, CA7 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.604E-09 | 6.986E-06 | CA1, CA12, CA2, CA4, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.585E-09 | 1.456E-05 | CA1, CA12, CA2, CA4, CA7 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 4.374E-08 | 7.327E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.251E-07 | 2.950E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.224E-06 | 7.842E-04 | AKR1B1, CYP1A1, CYP1A2, CYP1B1, NPC1, PPARD |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 1.613E-06 | 9.493E-04 | CYP1A1, LMNA, P4HB, PPARA, PPARD, TLR2 |
BP | GO:0050896; response to stimulus | GO:0009725; response to hormone | 3.019E-06 | 1.610E-03 | AKR1B1, CA2, CYP1A2, FABP3, NPC1, PPARA, TLR2, TSHR |
BP | GO:0008152; metabolic process | GO:0006631; fatty acid metabolic process | 3.491E-06 | 1.804E-03 | CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PPARD |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 3.565E-06 | 1.804E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0065007; biological regulation | GO:0048878; chemical homeostasis | 4.677E-06 | 2.108E-03 | AKR1B1, CA12, CA2, CA7, FABP3, FABP4, HTT, MAPK1, NPC1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 4.738E-06 | 2.108E-03 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 4.738E-06 | 2.108E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.074E-06 | 2.449E-03 | CA2, CA7 |
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 6.817E-06 | 2.650E-03 | AKR1B1, CYP1A1, CYP1B1, FABP3, MAPK1, NPC1, POLB, TLR2 |
BP | GO:0007610; behavior | GO:0007610; behavior | 9.121E-06 | 3.103E-03 | GAA, HTT, MAPK1, MAPT, NPC1, PPARA, TLR2 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 1.214E-05 | 4.004E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.396E-05 | 4.471E-03 | ALPI, CA1, CA12, CA2, CA4, CA7, PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0009636; response to toxic substance | 2.000E-05 | 6.050E-03 | AKR1B1, CYP1A1, CYP1B1, MAPK1, POLB, TLR2 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 2.863E-05 | 8.203E-03 | AKR1B1, CYP1A1, CYP1A2, CYP1B1, GAA, P4HB, PPARD, XDH |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.029E-05 | 8.470E-03 | CA1, CA2 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 3.716E-05 | 1.011E-02 | CYP1A1, CYP1A2, CYP1B1 |
CC | GO:0044464; cell part | GO:0005773; vacuole | 1.172E-04 | 2.438E-02 | AKR1B1, GAA, HTT, NPC1, RAB9A |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 1.228E-04 | 2.499E-02 | AKR1B1, MAPK1, MAPT |
CC | GO:0044421; extracellular region part | GO:0070062; extracellular exosome | 2.739E-04 | 4.849E-02 | AKR1B1, CA1, CA2, CA4, FABP3, FABP4, FABP5, GAA, MAPK1, NPC1, P4HB, RAB9A |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.256E-11 | 3.113E-09 | CA12, CA1, CA2, CA4, CA7 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 4.791E-10 | 3.306E-08 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 2.345E-05 | 8.091E-04 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 7.201E-05 | 1.988E-03 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.431E-04 | 3.292E-03 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.021E-04 | 3.984E-03 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.885E-05 | 8.091E-04 | CYP1A2, XDH |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 2.646E-03 | 3.053E-02 | MAPK1, PPARA, TSHR |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 4.696E-04 | 8.100E-03 | CA2, CA4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 8.025E-04 | 1.230E-02 | GAA, AKR1B1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; |